SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
23.9K Views
•
07:39 min
•
June 28th, 2019
DOI :
June 28th, 2019
•Chapters in this video
0:04
Title
1:06
Generation of Senescent Murine Embryonic Fibroblast (MEF) 12-15 Days
3:46
Senescent Associated -Galactosidase (SA--Gal) Screening Assay 2-3 Days
6:06
Results: Identification of Senotherapeutics by Measuring SA--Gal Activity in Single Cells
6:48
Conclusion
Related Videos
09:18
A Sensitive Method to Quantify Senescent Cancer Cells
20.7K Views
05:29
A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
2.8K Views
13:59
A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
8.2K Views
08:56
Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells
3.0K Views
14:01
Far-Red Fluorescent Senescence-Associated β-Galactosidase Probe for Identification and Enrichment of Senescent Tumor Cells by Flow Cytometry
4.7K Views
08:48
In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
3.3K Views
14:53
High-throughput Screening and Biosensing with Fluorescent C. elegans Strains
18.0K Views
09:51
Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase
854 Views
02:01
Sulforhodamine B Assay: A Sensitive Assay to Measure Drug Resistance Via Determination of Cellular Protein Content in Cancer Cells
1.5K Views
01:26
Flow Cytometry-Based Quantification of Therapy-Induced Senescent Cancer Cells
158 Views